''Functional Orthopedic Tissue Engineering'' Instructional Webcast to Take Place September 29, 2004.LARCHMONT, N.Y. -- A virtual seminar on "Functional Orthopedic orthopedic /or·tho·pe·dic/ (-pe´dik) pertaining to the correction of deformities of the musculoskeletal system; pertaining to orthopedics. Tissue Engineering," presented by Genetic Engineering News (www.GENseminars.com) and Tissue Engineering journal, will take place on September 29, 2004, at 12 pm EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT (NY time). This real-time webcast will address the major challenges in setting design constraints in the tissue engineering of load-bearing orthopedic structures, to ensure long-term functionality of the constructs after surgery. Presenting the talk will be David Butler, Ph.D., director of graduate studies in the department of biomedical engineering Biomedical engineering An interdisciplinary field in which the principles, laws, and techniques of engineering, physics, chemistry, and other physical sciences are applied to facilitate progress in medicine, biology, and other life sciences. at the University of Cincinnati The University of Cincinnati is a coeducational public research university in Cincinnati, Ohio. Ranked as one of America’s top 25 public research universities and in the top 50 of all American research universities,[2] . Peter C. Johnson, M.D., executive VP for life sciences and chief medical officer at Icoria, Inc. will moderate the event. This 90-minute virtual seminar will cover: use of functional tissue-engineering roadmap for strategic design; how to determine in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. forces and deformations to set design limits for repair constructs; benefits of stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young in enhancing the function of soft-tissue repair outcome; and functional tissue-engineering parameters for designing classes of repairs for orthopedic soft tissues. "Couple the demographic trend of aging populations in the developed world to the fact that increasing numbers of people of all ages are adopting more active lifestyles, and you have an orthopedics market that is set to explode," says John Sterling, editor in chief of Genetic Engineering News. "Current orthopedic technologies have limitations. This seminar will explore new techniques in tissue engineering and the use of stem cells, which offer a promise for treatment, management, and the possible eventual cure of a number of orthopedic-related diseases and injuries." Registrations for "Functional Orthopedic Tissue Engineering" are limited to ensure interactive participation. Following the presentation will be an extensive Q&A session, with worldwide participation. To register online and for further information, visit www.GENseminars.com. Genetic Engineering News (www.genengnews.com), the most widely read publication in the biotechnology industry, and Tissue Engineering journal, the leading resource for tissue engineering-engineering research and medicine, are published by Mary Ann Liebert, Inc., a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals peer-reviewed journal Refereed journal Academia A professional journal that only publishes articles subjected to a rigorous peer validity review process. Cf Throwaway journal. in cutting-edge areas of bioscience, medicine, engineering, law, and business. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion